[Chronic myeloid leukemia: up-to-date management]

MeSH terms

• Benzamides / administration & dosage*
• Benzamides / adverse effects
• Clinical Trials as Topic
• Dasatinib
• Drug Discovery / trends
• Drug Monitoring
• Fusion Proteins, bcr-abl / antagonists & inhibitors
• Fusion Proteins, bcr-abl / metabolism
• Hematopoietic Stem Cell Transplantation
• Humans
• Imatinib Mesylate
• Interferon-alpha / administration & dosage
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / classification
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
• Medication Adherence
• Molecular Targeted Therapy
• Piperazines / administration & dosage*
• Piperazines / adverse effects
• Practice Guidelines as Topic
• Prognosis
• Protein Kinase Inhibitors / administration & dosage*
• Protein Kinase Inhibitors / adverse effects
• Pyrimidines / administration & dosage*
• Pyrimidines / adverse effects
• Thiazoles / administration & dosage
• Thiazoles / adverse effects